106 related articles for article (PubMed ID: 17289802)
1. Preanalytical mRNA stabilization of whole bone marrow samples.
Langebrake C; Günther K; Lauber J; Reinhardt D
Clin Chem; 2007 Apr; 53(4):587-93. PubMed ID: 17289802
[TBL] [Abstract][Full Text] [Related]
2. Examination of stability of bone marrow blood RNA in the PAXgene tube.
Yamamoto T; Sekiyama A; Sekiguchi H; Yoshida T; Miyagi Y
Lab Hematol; 2006; 12(3):143-7. PubMed ID: 16950675
[TBL] [Abstract][Full Text] [Related]
3. Suitability of the PAXgene system to stabilize bone marrow RNA in imatinib-resistant patients with chronic myeloid leukemia.
Ernst T; Hoffmann J; Erben P; Hehlmann R; Hochhaus A; Müller MC
Clin Chem Lab Med; 2008; 46(3):318-22. PubMed ID: 18303987
[TBL] [Abstract][Full Text] [Related]
4. Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization.
Müller MC; Merx K; Weisser A; Kreil S; Lahaye T; Hehlmann R; Hochhaus A
Leukemia; 2002 Dec; 16(12):2395-9. PubMed ID: 12454744
[TBL] [Abstract][Full Text] [Related]
5. Impact of pre-analytical handling on bone marrow mRNA gene expression.
Breit S; Nees M; Schaefer U; Pfoersich M; Hagemeier C; Muckenthaler M; Kulozik AE
Br J Haematol; 2004 Jul; 126(2):231-43. PubMed ID: 15238145
[TBL] [Abstract][Full Text] [Related]
6. Stabilization of mRNA expression in whole blood samples.
Rainen L; Oelmueller U; Jurgensen S; Wyrich R; Ballas C; Schram J; Herdman C; Bankaitis-Davis D; Nicholls N; Trollinger D; Tryon V
Clin Chem; 2002 Nov; 48(11):1883-90. PubMed ID: 12406972
[TBL] [Abstract][Full Text] [Related]
7. Preanalytical robustness of blood collection tubes with RNA stabilizers.
Stellino C; Hamot G; Bellora C; Trouet J; Betsou F
Clin Chem Lab Med; 2019 Sep; 57(10):1522-1529. PubMed ID: 31112504
[TBL] [Abstract][Full Text] [Related]
8. [Use of nanocolonies for detection of minimal residual disease in patients with leukemia t(8;21)].
Falaleeva MV; Chetverina EV; Kravchenko AV; Chetverin AB
Mol Biol (Mosk); 2009; 43(1):180-9. PubMed ID: 19334541
[TBL] [Abstract][Full Text] [Related]
9. Concomitant aberrant overexpression of RUNX1 and NCAM in regenerating bone marrow of myeloid leukemia of Down's syndrome.
Langebrake C; Klusmann JH; Wortmann K; Kolar M; Puhlmann U; Reinhardt D
Haematologica; 2006 Nov; 91(11):1473-80. PubMed ID: 17043020
[TBL] [Abstract][Full Text] [Related]
10. Optimization of the PAXgene blood RNA extraction system for gene expression analysis of clinical samples.
Chai V; Vassilakos A; Lee Y; Wright JA; Young AH
J Clin Lab Anal; 2005; 19(5):182-8. PubMed ID: 16170815
[TBL] [Abstract][Full Text] [Related]
11. The differences and correlations of BCR-ABL transcripts between peripheral blood and bone marrow assays are associated with the molecular responses in the bone marrow for chronic myelogenous leukemia.
Jiang Q; Zhao XY; Qin YZ; Liu YR; Lai YY; Jiang B; Huang XJ
Am J Hematol; 2012 Dec; 87(12):1065-9. PubMed ID: 22965919
[TBL] [Abstract][Full Text] [Related]
12. Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA.
Miyajima Y; Kato K; Numata S; Kudo K; Horibe K
Cancer; 1995 Jun; 75(11):2757-61. PubMed ID: 7743482
[TBL] [Abstract][Full Text] [Related]
13. Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients.
van Wezel EM; Decarolis B; Stutterheim J; Zappeij-Kannegieter L; Berthold F; Schumacher-Kuckelkorn R; Simon T; Fiocco M; van Noesel MM; Caron HN; van der Schoot CE; Hero B; Tytgat GAM
Eur J Cancer; 2016 Feb; 54():149-158. PubMed ID: 26796600
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow biopsy imprint preparations: use for molecular diagnostics in leukemias.
Crisan D; Farkas DH
Ann Clin Lab Sci; 1993; 23(6):407-22. PubMed ID: 8291896
[TBL] [Abstract][Full Text] [Related]
15. Predictive potential of testing for bone marrow involvement in Ewing tumor patients by RT-PCR: a preliminary evaluation.
Zoubek A; Ladenstein R; Windhager R; Amann G; Fischmeister G; Kager L; Jugovic D; Ambros PF; Gadner H; Kovar H
Int J Cancer; 1998 Feb; 79(1):56-60. PubMed ID: 9495359
[TBL] [Abstract][Full Text] [Related]
16. Clock gene expression in purified mouse hematopoietic stem cells.
Tsinkalovsky O; Rosenlund B; Laerum OD; Eiken HG
Exp Hematol; 2005 Jan; 33(1):100-7. PubMed ID: 15661403
[TBL] [Abstract][Full Text] [Related]
17. RNA Amplification Protocol Leads to Biased Polymerase Chain Reaction Results Especially for Low-Copy Transcripts of Human Bone Marrow-Derived Stromal Cells.
Coenen C; Liedtke S; Kogler G
PLoS One; 2015; 10(10):e0141070. PubMed ID: 26485654
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of the PAXgene™ bone marrow RNA system for stabilizing total RNA.
Takeda M; Funato T; Ikemoto M; Nanmoku T; Urasaki Y; Iwatani Y
J Clin Lab Anal; 2015 Jan; 29(1):61-7. PubMed ID: 24687367
[TBL] [Abstract][Full Text] [Related]
19. Expressions of transcription factors in goldfish (Carassius auratus L.) macrophages and their progenitors.
Katzenback BA; Foroutanpay BV; Belosevic M
Dev Comp Immunol; 2013 Oct; 41(2):230-9. PubMed ID: 23748037
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
